Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
44.22
+0.75 (1.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Revenue by Geography
History
| Date | North America | Latin America | Europe | Japan |
|---|---|---|---|---|
| Sep 30, 2024 | 316.40M | 130.30M | 69.60M | 6.40M |
| Jun 30, 2024 | 307.30M | 109.50M | 60.40M | 4.10M |
| Mar 31, 2024 | 297.70M | 89.70M | 54.20M | - |
| Dec 31, 2023 | 307.10M | 77.30M | 47.60M | 2.20M |
| Sep 30, 2023 | 299.00M | 67.40M | 42.70M | - |
| Jun 30, 2023 | 298.20M | 64.30M | 38.10M | - |
| Mar 31, 2023 | 286.20M | 57.70M | 37.60M | 2.40M |
| Dec 31, 2022 | 281.00M | 44.70M | 36.40M | - |
| Sep 30, 2022 | 267.10M | 41.80M | 33.20M | 1.20M |
| Jun 30, 2022 | 267.00M | 35.20M | 32.00M | - |
| Mar 31, 2022 | 275.30M | 27.40M | 29.20M | - |
| Dec 31, 2021 | 301.10M | 23.60M | 26.60M | - |
| Sep 30, 2021 | 312.90M | 21.40M | 25.10M | - |
| Jun 30, 2021 | 318.70M | 17.70M | 22.90M | - |
| Mar 31, 2021 | 295.00M | 16.20M | 22.70M | - |
| Dec 31, 2020 | 237.70M | 12.00M | 21.30M | - |
| Sep 30, 2020 | 185.10M | 10.70M | 19.30M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.